Strati, P., Ferrajoli, A., Lerner, S., O’Brien, S., Wierda, W., Keating, M. J., & Faderl, S. (2013). Fludarabine, cyclophosphamide, and rituximab (FCR) plus GM-CSF as frontline treatment for patients with Chronic Lymphocytic Leukemia. Leuk Lymphoma.

Strati, Paolo, Alessandra Ferrajoli, Susan Lerner, Susan O’Brien, William Wierda, Michael J. Keating, och Stefan Faderl. "Fludarabine, Cyclophosphamide, and Rituximab (FCR) Plus GM-CSF As Frontline Treatment for Patients With Chronic Lymphocytic Leukemia." Leuk Lymphoma 2013.

Strati, Paolo, et al. "Fludarabine, Cyclophosphamide, and Rituximab (FCR) Plus GM-CSF As Frontline Treatment for Patients With Chronic Lymphocytic Leukemia." Leuk Lymphoma 2013.